Cargando…

Analysis of Systemic Inflammatory Factors and Survival Outcomes in Endometrial Cancer Patients Staged I-III FIGO and Treated with Postoperative External Radiotherapy

Background: The causal link between elevated systemic inflammation biomarkers and poor survival has been demonstrated in cancer patients. However, the evidence for this correlation in endometrial cancer (EC) is too weak to influence current criteria of risk assessment. Here, we examined the role of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Holub, Katarzyna, Busato, Fabio, Gouy, Sebastien, Sun, Roger, Pautier, Patricia, Genestie, Catherine, Morice, Philippe, Leary, Alexandra, Deutsch, Eric, Haie-Meder, Christine, Biete, Albert, Chargari, Cyrus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291051/ https://www.ncbi.nlm.nih.gov/pubmed/32408668 http://dx.doi.org/10.3390/jcm9051441

Ejemplares similares

Interaction between the Number of Chemotherapy Cycles and Brachytherapy Dose/Volume Parameters in Locally Advanced Cervical Cancer Patients
por: Escande, Alexandre, et al.
Publicado: (2020)

Cervical Cancer and Fertility-Sparing Treatment
por: Zaccarini, François, et al.
Publicado: (2021)

Total Reference Air Kerma is Associated with Late Bowel Morbidity in Locally Advanced Cervical Cancer Patients Treated with Image-Guided Adaptive Brachytherapy
por: Bockel, Sophie, et al.
Publicado: (2019)

Neutrophilia in locally advanced cervical cancer: A novel biomarker for image-guided adaptive brachytherapy?
por: Escande, Alexandre, et al.
Publicado: (2016)

False negative rate at (18)F-FDG PET/CT in para-aortic lymphnode involvement in patients with locally advanced cervical cancer: impact of PET technology
por: Gouy, Sebastien, et al.
Publicado: (2021)

Current Standards in the Management of Early and Locally Advanced Cervical Cancer: Update on the Benefit of Neoadjuvant/Adjuvant Strategies
por: Zhou, Yuedan, et al.
Publicado: (2022)

Brachytherapy for the Conservative Treatment of Female Peri-Urethral Carcinoma
por: Andraud, Mickaël, et al.
Publicado: (2022)

Prediction of cervical cancer recurrence using textural features extracted from (18)F-FDG PET images acquired with different scanners
por: Reuzé, Sylvain, et al.
Publicado: (2017)

Is uterine preservation combined with bilateral salpingo-oophorectomy to promote subsequent fertility safe in infiltrative mucinous ovarian cancer?
por: Gouy, Sebastien, et al.
Publicado: (2017)

Staging surgery in early-stage ovarian mucinous tumors according to expansile and infiltrative types
por: Gouy, Sebastien, et al.
Publicado: (2017)

Locally advanced cervical cancer with bladder invasion: clinical outcomes and predictive factors for vesicovaginal fistulae
por: Sun, Roger, et al.
Publicado: (2018)

Correlation between pelvic bone marrow radiation dose and acute hematological toxicity in cervical cancer patients treated with concurrent chemoradiation
por: Kumar, T, et al.
Publicado: (2019)

Changes in DNA Damage Response Markers with Treatment in Advanced Ovarian Cancer
por: Kubelac, Paul, et al.
Publicado: (2020)

Image-Guided Brachytherapy for Salvage Reirradiation: A Systematic Review
por: Bockel, Sophie, et al.
Publicado: (2021)

New pre-treatment eosinophil-related ratios as prognostic biomarkers for survival outcomes in endometrial cancer
por: Holub, Katarzyna, et al.
Publicado: (2018)

Providing Patients with Locally Advanced Cervical Cancer Access to Brachytherapy: Experience from a Referral Network for Women Treated in Overseas France
por: Bentahila, Rita, et al.
Publicado: (2022)

Clinical utility of SMARCA4 testing by immunohistochemistry in rare ovarian tumours
por: Genestie, Catherine, et al.
Publicado: (2019)

Phase I trial evaluating the antiviral agent Cidofovir in combination with chemoradiation in cervical cancer patients
por: Deutsch, Eric, et al.
Publicado: (2016)

Metabolic features of cancer cells impact immunosurveillance
por: Joseph, Adrien, et al.
Publicado: (2021)

Implementation of Image-Guided Brachytherapy for Pediatric Vaginal Cancers: Feasibility and Early Clinical Results
por: Terlizzi, Mario, et al.
Publicado: (2022)

Neoadjuvant chemotherapy alters the balance of effector to suppressor immune cells in advanced ovarian cancer
por: Leary, Alexandra, et al.
Publicado: (2020)

FIGO staging of endometrial cancer: 2023
por: Berek, Jonathan S., et al.
Publicado: (2023)

Management of Endometrial Cancer: French Society of Onco-Gynecology‘s Evaluation through a Delphi Survey
por: Marti, Carolin, et al.
Publicado: (2022)

Postoperative radiotherapy for endometrial cancer
por: Choi, Eun Cheol, et al.
Publicado: (2012)

Increased bone marrow SUVmax on 18F-FDG PET is associated with higher pelvic treatment failure in patients with cervical cancer treated by chemoradiotherapy and brachytherapy
por: Seban, Romain-David, et al.
Publicado: (2019)

Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT) beyond SMARCA4 Mutations: A Comprehensive Genomic Analysis
por: Auguste, Aurélie, et al.
Publicado: (2020)

Outcomes of “sandwich” chemoradiotherapy compared with chemotherapy alone for the adjuvant treatment of FIGO stage III endometrial cancer
por: Wang, Shao-Jing, et al.
Publicado: (2022)

Pulse-dose-rate interstitial brachytherapy in anal squamous cell carcinoma: clinical outcomes and patients’ health quality perception
por: Bourdais, Rémi, et al.
Publicado: (2021)

Risk Stratification of Endometrial Cancer Patients: FIGO Stage, Biomarkers and Molecular Classification
por: Kasius, Jenneke C., et al.
Publicado: (2021)

Adjuvant brachytherapy for FIGO stage I serous or clear cell endometrial cancer
por: Jeans, Elizabeth B, et al.
Publicado: (2021)

Nomogram Predicting Overall Survival in Patients with FIGO II to III Squamous Cell Cervical Carcinoma Under Radical Radiotherapy: A Retrospective Analysis Based on 2018 FIGO Staging
por: Zang, Lele, et al.
Publicado: (2021)

Radical hysterectomy with adjuvant radiotherapy versus radical radiotherapy for FIGO stage IIB cervical cancer
por: Chai, Yanlan, et al.
Publicado: (2014)

The percentage of peripheral eosinophils as a sensitive marker for differentiating FIGO grade in endometrial adenocarcinomas
por: Akış, Serkan, et al.
Publicado: (2022)

Molecular Classification of Endometrial Cancer and the 2023 FIGO Staging: Exploring the Challenges and Opportunities for Pathologists
por: Zheng, Wenxin
Publicado: (2023)

Impact of concurrent chemotherapy on definitive radiotherapy for women with FIGO IIIb cervical cancer
por: Kuroda, Yuuki, et al.
Publicado: (2012)

Risk stratification of abdominopelvic failure for FIGO stage III epithelial ovarian cancer patients: implications for adjuvant radiotherapy
por: Chang, Jee Suk, et al.
Publicado: (2013)

In vivo imaging of uterine cervix with a Mueller polarimetric colposcope
por: Vizet, Jérémy, et al.
Publicado: (2017)

Does the use of the 2009 FIGO classification of endometrial cancer impact on indications of the sentinel node biopsy?
por: Ballester, Marcos, et al.
Publicado: (2010)

Impact of the adjuvant management and risk factors on survival in FIGO stage 3 endometrial cancer patients
por: Tong, Nora, et al.
Publicado: (2023)

EQD2 Analyses of Vaginal Complications in Exclusive Brachytherapy for Postoperative Endometrial Carcinoma
por: Zhang, Yaowen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_l8p26njple7pg3st6k3gbchpda